Samsung Medison
| Company type | Subsidiary |
|---|---|
| Industry | Medical equipment |
| Founded | 1985 |
| Fate | Acquired by Samsung Electronics in 2010 |
| Headquarters | Seoul , South Korea |
Area served | Worldwide (110 countries as of 2020) |
| Products | Diagnostic ultrasound equipment, medical imaging devices |
| Parent | Samsung Electronics |
| Website | www |
Samsung Medison Co., Ltd. (Template:Ko-hhrm) specializes in the production of diagnostic ultrasound equipment. Established in 1985, the company became part of Samsung in 2010, following an acquisition valued at over $262 million USD. By 2020, Samsung Medison's medical devices were distributed across 110 countries, accounting for approximately 85 percent of its overall revenue.
History
In 2016, Samsung presented the FDA-approved GM85 Mobile Digital Radiography System at the Radiological Society of North America's (RSNA) 102nd Scientific Assembly and Annual Meeting held in Chicago. This system was developed through collaboration with Samsung Medison.
The year 2017 saw the launch of the HS40 ultrasound system by Samsung Medison, designed specifically to enhance obstetric diagnostic capabilities. This addition enabled the company to offer a comprehensive range of medical devices.
At the RSNA 2018 Annual Meeting in Chicago, Samsung Electronics and Samsung Medison unveiled multiple diagnostic imaging software solutions, emphasizing advancements in medical imaging technology.
In 2019, Samsung Medison introduced the HERA I10 Combination Ultrasound System. This system integrates an ultrasound examination chair with advanced IT, semiconductor image processing, and communication technologies to support diagnostic procedures.
By 2020, Samsung Medison, alongside Samsung Electronics, announced its formal entry into the broader medical device market, including a focus on diagnostic ultrasound technologies.